Related by context. Frequent words. (Click for all words.) 65 limiting toxicity 64 Natalizumab 64 Secondary endpoints include 64 elotuzumab 64 tipranavir 63 tanespimycin 62 lymphopenia 62 heavily pretreated 62 surrogate endpoint 62 achieved statistical significance 62 pertuzumab 61 mg QD 61 vandetanib 61 tumor lysis syndrome 61 virologic 61 mg kg dose 61 nab paclitaxel 61 Secondary endpoints included 60 pharmacodynamic effects 60 interferon alfa 60 antithrombotic 60 Traficet EN 60 mg BID 60 sustained virologic response 60 patients evaluable 60 chemoradiotherapy 60 eszopiclone 60 decitabine 60 mycophenolate mofetil 59 Diamyd ® 59 DOXIL 59 GFT# 59 antitumor activity 59 azacitidine 59 CA4P 59 fulvestrant 59 tolvaptan 59 TORISEL 59 hypomagnesemia 59 neoadjuvant 58 plus dexamethasone 58 INTEGRILIN 58 TNF α 58 ponatinib 58 cardiac toxicity 58 virologic failure 58 ZD# [001] 58 hypercalcemia 58 seroprotection 58 mcg kg 58 hyperglycaemia 58 bosentan 58 chlorambucil 58 antiangiogenic 58 mRCC 58 axitinib 58 angiogenesis inhibitor 58 lupus nephritis 58 acute coronary syndromes ACS 58 COPAXONE R 58 rotigotine 58 temsirolimus 58 monotherapy 58 pazopanib 58 TAXUS Stent 58 platelet activation 57 glucose homeostasis 57 PROMACTA 57 virologic response 57 mucosal healing 57 Laquinimod 57 tocilizumab 57 adalimumab 57 pharmacokinetic profiles 57 febrile neutropenia 57 daunorubicin 57 peginterferon alfa 2b 57 indolent NHL 57 platelet inhibition 57 IFN alpha 57 peginterferon 57 CMV infection 57 nitazoxanide 57 cytogenetic response 57 cabazitaxel 57 evaluable 57 plus methotrexate 57 hepatotoxicity 57 irbesartan 57 gout flares 57 octreotide 57 T2DM 57 superficial bladder cancer 57 Cloretazine R VNP#M 57 raltegravir 57 Combination therapy 57 optimal dosing 57 atacicept 57 C1 INH 57 sunitinib 57 thromboembolic events